Eris Lifesciences Limited has informed the Exchange about Action(s) taken or orders passed

Sebi PenaltyRegulatory & Legal View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.0%1-day move

₹1353.40

prior close

₹1350.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.2+0.8+0.3+0.7+2.0+0.6+3.0+1.1+0.5+1.3+6.8+3.5——

Up moveDown movePending

AI summary

BSE and NSE have each imposed a fine of ₹4,24,800 on Eris Lifesciences for non-compliance with Regulation 17(1) of SEBI Listing Regulations, which pertains to the composition of the Board of Directors. The non-compliance was for the quarter ended March 31, 2026, arising from a board vacancy after an Independent Director's term ended. The company filled the vacancy effective March 14, 2026, and states it has been compliant since then. The total combined penalty from both exchanges is ₹8,49,600. The company clarified that the matter has been rectified.

Likely market impact

The financial impact is limited to ₹4,24,800 per exchange (total ₹8,49,600). This is a relatively minor regulatory penalty for a governance-related technical non-compliance that has already been corrected.